Molq Lab

What Molq Lab does

MolQ Laboratory is a NABL-accredited, ISO 9001:2008-certified clinical diagnostics reference laboratory headquartered in Gurugram, Haryana, India, operating as a unit of Molecular Quest Pvt. Ltd. under the MDS-Meta Designs Solution parent umbrella. Founded in 2012 by Dr. Amit Verma — a molecular oncologist trained at AIIMS-Delhi and MD Anderson — and CEO Sunil Goyal, the company runs a 10,000 sqft national clinical and anatomic reference laboratory staffed by 200+ employees and supports a 2,000+ test menu spanning routine pathology, biochemistry, immunology, infectious disease panels, and specialized cancer genetics and molecular diagnostics (NGS, PCR, Flow Cytometry, FISH, IHC, HPLC). Its core products are organized into individual tests (₹160–₹6,850), packaged health screening bundles (₹960–₹4,480, with 16–20% discounts), and high-complexity genetic and oncology tests (₹3,500–₹100,000), complemented by home sample collection and an online patient report portal.

The company operates a dual go-to-market: direct-to-consumer via website, mobile app, and home phlebotomy visits across Delhi-NCR, paired with a B2B partner portal serving hospitals, children's hospitals, regional hospital networks, commercial laboratories, and government/military facilities. Customer segments are split between individual patients (B2C, primary) and healthcare institutions (B2B, primary), with corporate wellness and government contracts as secondary segments. Pricing is pay-as-you-go per test with no disclosed subscription or recurring contracts, and revenue is not publicly disclosed. Regulatory credentials (NABL, ICMR recognition, DSIR certification) and a specialist leadership roster drawn from AIIMS, MD Anderson, and Mount Sinai provide the institutional credibility required for hospital and government procurement. MolQ has reported over 1,000,000 cumulative satisfied customers served in Delhi-NCR since inception, with no venture funding, no acquisitions, and no disclosed expansion beyond the Delhi-NCR primary service region.

The company's competitive positioning centers on oncology and genetic specialization within a fragmented Indian diagnostic market, where it competes against larger national chains (Dr. Lal PathLabs, Metropolis, SRL, Thyrocare) on specialized cancer genetics expertise rather than scale or price. The specialist co-founder profile, four-layer regulatory credentialing, and dedicated B2B portal constitute the primary defensible assets, while the absence of disclosed revenue, no venture funding to date, and a single-region operating footprint represent material constraints on scale and growth trajectory visibility.

Name

Molq Lab

Legal name

MolQ Laboratory

Website

https://molq.in

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

MolQ Laboratory is a NABL-accredited Indian reference lab in Gurugram offering 2,000+ diagnostic tests spanning routine pathology to specialized cancer genetics and molecular diagnostics, serving individual consumers and healthcare institutions across Delhi-NCR via home sample collection and a B2B partner portal.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Diagnostic laboratory services
• Molecular diagnostic testing
• Genetic testing services
• Pathology services
• Preventive health screening

Headquarters

HQ city

Haryana

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Diagnostic Laboratory Services: Direct revenue from conducting clinical diagnostic tests including pathology, molecular, and genetic tests for individual patients and healthcare facilities
2. Health Screening Packages: Pre-packaged diagnostic bundles covering comprehensive health assessments across various conditions including wellness, diabetes, cardiac, fertility, and cancer screening
3. Genetic Testing Services: Specialized molecular and genetic diagnostics including NGS panels, BRCA testing, liquid biopsy, and hereditary cancer screening

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

MolQ Laboratory operates a NABL-accredited clinical and anatomic reference laboratory in Gurugram, offering over 2,000 diagnostic and pathology tests across routine pathology, molecular diagnostics, and genetic testing. The company serves individual patients through direct online booking, home sample collection, and digital report access, and serves healthcare providers and corporate clients through a dedicated B2B portal.

Product overview

MolQ Laboratory is a NABL-accredited diagnostic service provider offering over 2,000 clinical, research, and diagnostic tests across multiple health domains. The portfolio consists of comprehensive health screening packages (Smart Health Package, General Screening, Wellness Packages for seniors), disease-specific diagnostic panels (Cancer Screening, Diabetes, Cardiac, Thyroid, Fertility, Hepatitis, COVID), individual diagnostic tests (CBC, LFT, KFT, Lipid Profile), genetic testing services (Onco Genetics, BRCA, FISH, NIPT, PCR), and specialized pathology services (IHC, Flow Cytometry, Histopathology). The company operates as a single unified laboratory service with home sample collection capabilities, offering tests across Oncology, Genetics, Infectious Diseases, and general Pathology. The testing menu ranges from routine screening to highly specialized molecular and genetic assays, with results delivered online through their patient portal.

Differentiator

Problem solved

Functional benefit

Products and services

• MolQ Health Screening Packages Comprehensive health assessment bundles combining 4-94 parameters across multiple organ systems, intended for individuals seeking preventive wellness checkups.
• MolQ Cancer Screening Panels Multi-marker cancer screening panels tailored for males and females, combining tumor markers, liver/kidney function, and infectious disease screening.
• MolQ Diabetes Screen & Diabetes Package Diabetes screening and management panels measuring glycemic control, lipid metabolism, kidney function, and iron status.
• MolQ Heart/Cardiac Care Package Cardiovascular risk assessment packages combining glycemic, lipid, and inflammatory markers.
• MolQ Thyroid Profile Thyroid function and antibody testing across multiple variants for evaluation of thyroid disorders.
• MolQ Liver Function Test (LFT) Liver function assays measuring hepatic enzymes, proteins, and bilirubin across 8-9 parameters.
• MolQ Kidney Function Test (KFT/RFT) Renal function assays measuring urea, creatinine, uric acid, electrolytes, and minerals.
• MolQ Lipid Profile Cardiovascular lipid assays including cholesterol, triglycerides, HDL, LDL, and extended apolipoprotein markers.
• MolQ Complete Blood Count (CBC) Hematology testing including CBC, ESR, peripheral smear, and complete haemogram analysis.
• MolQ COVID-19 Testing Panels COVID-19 inflammatory and coagulation marker panels for severity monitoring and disease management.
• MolQ Hepatitis Profile Serological screening panels for hepatitis A, B, C, and E infection status and immunity.
• MolQ Fertility Panel Hormonal and semen-based fertility assessment for males and females with multiple parameter variants.
• MolQ Genetic Testing - Onco Genetics Specialized cancer genetic testing using somatic panels, liquid biopsy, and BRCA 1&2 analysis with genetic counseling.
• MolQ Non-Invasive Prenatal Testing (NIPT) Non-invasive prenatal screening for chromosomal abnormalities and microdeletions from maternal blood.
• MolQ BRCA 1&2 Testing Germline and somatic BRCA 1&2 gene testing for hereditary breast and ovarian cancer risk assessment.
• MolQ FISH Testing Cytogenetic oncology FISH testing for cancer gene rearrangements and amplification markers.
• MolQ Real-Time PCR Testing Molecular PCR-based testing for infectious disease detection, genetic mutations, and pharmacogenomic markers.
• MolQ IHC / Immunohistochemistry Tumor immunohistochemistry profiling for HER2, ER/PR, Ki-67, PDL-1, ALK, ROS1, and microsatellite instability markers.
• MolQ Flow Cytometry Flow cytometry-based CD4/CD8 enumeration and leukemia/lymphoma immunophenotyping.
• MolQ Histopathology Tissue-based histopathology services covering processing, staining, microscopy, and diagnostic reporting.
• MolQ Home Sample Collection Service Phlebotomist-driven doorstep sample collection across Delhi-NCR for all booked diagnostic tests, with online tracking and same-day reporting for routine assays.
• MolQ Maternal/Pregnancy Screening Prenatal and antenatal screening panels including dual/triple/quad marker, TORCH, and glucose tolerance testing.
• MolQ Vitamins & Minerals Profile Vitamin and mineral deficiency panels including Vitamin D3, B12, folic acid, and broader mineral assays.

Quantifiable outcome

• Over 1,000,000 satisfied customers served
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Molecular Quest Healthcare Pvt LtdcoreStrategic or Co-development Partner · 1 January 2012Parent company under the MDS- Meta Designs Solution umbrella. Molecular Quest Healthcare Pvt Ltd operates as the healthcare division providing diagnostic services through MolQ Laboratory.
• Pathkits Healthcare Private LtdcoreStrategic or Co-development Partner · 1 January 2012Subsidiary company under MDS- Meta Designs Solution focused on manufacturing healthcare products, operating alongside the diagnostic services division.
• MDS- Meta Designs Solution (Parent Company)coreOthers · 1 January 2012Parent company led by CEO Sunil Chand Goyal, encompassing subsidiaries in Diagnostics (Molecular Quest Healthcare Pvt Ltd), Manufacturing (Pathkits Healthcare Private Ltd), and other business ventures in Healthcare, Entertainment, and IT.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Dr. Lal PathLabs: Largest Indian diagnostic chain with NABL accreditation offering 4,000+ tests including molecular and genetic diagnostics through pan-India patient service centers. Directly comparable to MolQ on test menu breadth, B2C home collection model, and hospital reference partnerships.
• Thyrocare Technologies: National preventive and wellness diagnostics provider with package-based pricing very similar to MolQ's Smart Health and General Screening bundles. Both compete for B2C preventive health consumers through digital booking and home collection.
• Metropolis Healthcare: Pan-India NABL-accredited chain with strong molecular and genetic testing capabilities serving hospitals and patients. Comparable to MolQ on esoteric testing (oncology, genetics), B2B hospital partnerships, and home collection services.
• SRL Diagnostics (Agilus): One of India's largest reference laboratory networks with NABL accreditation and deep molecular diagnostics expertise. Directly comparable to MolQ in serving hospitals, corporate clients, and government/military institutions with comprehensive test menus.
• Apollo Diagnostics: Hospital-anchored diagnostic chain offering routine and specialized tests including cancer markers and genetics through home collection. Comparable on B2C packages, hospital reference work, and digital booking infrastructure.
• Oncquest Laboratories: Specialized oncology and molecular diagnostics reference lab in India offering NGS, FISH, IHC, and BRCA panels — directly overlapping with MolQ's cancer genetics niche. Comparable on esoteric testing menu and hospital B2B partnerships.

Emerging players

• Tata 1mg (Diagnostics): Digital-first healthcare platform with diagnostic booking, home collection, and integrated pharmacy/consultation services. Comparable to MolQ on D2C digital booking motion and home sample collection, though broader in healthcare services.
• Healthians: Digital-native preventive diagnostics platform focused on home sample collection and wellness packages across North India. Overlaps with MolQ on preventive health screening bundles, phlebotomist network, and Delhi-NCR customer base.
• Pathkind Labs: Emerging national diagnostic chain expanding into molecular and specialty testing with franchise-driven reach. Comparable to MolQ on test menu breadth and home collection expansion strategy, though earlier in geographic scaling.

Regional players

• Suburban Diagnostics: West India-focused diagnostic chain with NABL-accredited labs offering molecular diagnostics and home collection. Comparable on routine-to-specialized test mix and hospital reference services, though geographically separate from MolQ's Delhi-NCR stronghold.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@molqcertifiedpathologylab9666
• Facebookfacebook.com/molqlaboratory
• LinkedInlinkedin.com/company/molq-laboratory/about
• Instagraminstagram.com/molqlaboratory

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molq Lab